FUREN Group Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares FUREN Group Pharmaceutical Co Ltd with three other
companies in this sector in China:
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
sales of 6.36 billion Chinese Renmimbi [US$950.74 million]
Hubei Jumpcan Pharmaceutical Co Ltd
(7.08 billion Chinese Renmimbi [US$1.06 billion]
China Medical System Holdings Limited
(5.43 billion Chinese Renmimbi [US$812.41 million]
of which 100%
was Pharmaceutical Products).
FUREN Group Pharmaceutical Co Ltd reported sales of 6.23 billion Chinese Renmimbi (US$932.04 million)
December of 2018.
increase of 7.5%
versus 2017, when the company's sales were 5.80 billion Chinese Renmimbi.
Sales at FUREN Group Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2013, sales have increased a total of 1,497%).